Fig. 4From: The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivoa Fullerenol NPs ameliorate hyperlipidemia by modulating gut microbiota structure and increasing SCFA production. b Fullerenol NPs contain furan- and pyran-like structures that could be used by gut microbesBack to article page